3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
6
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gastrointestinal
1
Breast
1
Conditions
Mesothelioma
2
Solid Tumors
1
Solid Tumor, Adult
1
Solid Tumor
1
Retinoblastoma
1
Pseudomyxoma Peritonei
1
Mesothelioma, Malignant
1
Lung Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Colonic Neoplasms
1
Childhood Solid Tumor
1
Carcinoma, Ovarian Epithelial
1
Appendiceal Neoplasms
1
Advanced Cancers
1
Advanced Cancer
1
Interventions
pembrolizumab
2
SS1(dsFv)PE38
2
tislelizumab
1
spartalizumab
1
entinostat
1
Surveys and Questionnaires
1
Referral and Consultation
1
Polymerase Chain Reaction
1
Paclitaxel
1
PM 01183
1
Nivolumab
1
Microarray Analysis
1
Irinotecan
1
Interleukin-2
1
Immunoenzyme Techniques
1
Gene Expression Profiling
1
Flow Cytometry
1
Fentanyl
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Surveys and Questionnaires
×
Other solid neoplasm
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled